Menopause Symptoms And Gynecological Diseases

"When menopause comes, how long on earth do the symptoms last?" is one of the questions heard most often in the consultation room. The average age of menopause in Korean women is known to be around 49, and if there is no period for 12 months after the last menstruation, it is regarded as menopause. However, menopause is not an event that stops abruptly on a single day but a process of hormonal change over several years, so the start and end of symptoms also vary widely from person to person. In this article, I organize, from a care perspective, how long menopausal symptoms usually last and the gynecologic conditions that must be examined during this period.

Understanding the time before and after menopause, rather than menopause itself, is the starting point for understanding symptoms. Menopause refers to a state in which ovarian function has stopped and menstruation has permanently ceased, diagnosed retrospectively at the point 12 months after the last menstrual day. In contrast, the period during which hormones fluctuate and symptoms appear before and after is separately called the menopausal transition or climacteric.

According to the Korea Disease Control and Prevention Agency's national health information portal materials, the menopausal transition usually begins 3 to 4 years before menopause and lasts on average about 4 years, as short as 2 years and as long as about 8 years. That is, symptoms can already begin before menstruation completely stops.

• Perimenopause: the overall period around menopause
• Menopausal transition: the roughly 4-year stretch from when the menstrual cycle begins to be disrupted to reaching menopause
• Postmenopause: the period after the last menstruation

In the consultation room, many people come after putting it off, thinking "I still have periods, so it cannot be the climacteric," but symptoms commonly arrive before the declaration of menopause. The change of periods becoming infrequent is addressed in more detail in the article for those wondering whether infrequent periods mean menopause.

The duration of menopausal symptoms is hard to pin down to a single number of "an average of so many years." What I, as the director, always emphasize to patients is exactly individual variation. There are people whose symptoms subside within a few months, and there are people whose symptoms continue for over 10 years.

Still, there is evidence showing a broad trend. A report based on the SWAN study, which long-tracked women across several U.S. regions (Avis et al., Duration of menopausal vasomotor symptoms, 2015), reports that when vasomotor symptoms such as facial flushing and sweating are frequent, their duration exceeds a median of 7 years. The North American Menopause Society (NAMS) also explains that vasomotor symptoms can continue for a considerable period after the last menstruation, as long as several years.

So it is hard to conclude "the hormone test values are fine, so the symptoms will soon end too." Even in the same menopausal period, the type, intensity, and duration of symptoms appear differently from person to person, so in the end the direction of management is set based on the symptoms themselves.

The reason menopausal symptoms are so diverse is that estrogen was a hormone working all over the body. As ovarian function declines and estrogen decreases, changes appear at once in the various organs that had been under its influence.

Representatively, the following symptoms are reported.

Of these, vaginal dryness, painful intercourse, and urinary discomfort are grouped separately under the name genitourinary syndrome of menopause (GSM). This concept was organized jointly by the International Society for the Study of Women's Sexual Health (ISSWSH) and NAMS in 2014 and refers to the group of symptoms appearing as the tissue around the vagina and urethra changes due to decreased estrogen. Unlike vasomotor symptoms, it tends to progress gradually rather than improve on its own over time, so it often needs separate management. Related self-care tips can be checked in menopausal vaginal dryness self-diagnosis and management.

The goal of menopausal management is not "stopping menopause" but "reducing uncomfortable symptoms and protecting long-term health." So rather than a single correct answer, a choice fitted to the type of symptoms and one's own health state is important.

If symptoms are to a degree that affects daily life, you discuss with your physician and review several methods including hormone therapy. NAMS's position materials present hormone therapy as the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause, and explain that generally starting relatively early after the last menstruation is advantageous in terms of the benefit-risk balance. However, since it cannot be recommended identically to everyone, it is decided by weighing past history and risk factors together.

When hormone therapy is not suitable, other methods such as a non-hormonal approach or local treatment are considered together. If you are curious about the direction that fits you, we recommend a consultation without burden.

The specific treatment items and screening composition can be examined in the menopausal hormone therapy guide and the menopause screening program, and costs will be explained after consultation.

The reason gynecologic screening is important around menopause is that, during this period, several changes related to hormone deficiency overlap at once. When ovarian function stops and estrogen becomes deficient, the problems that can arise from that influence must be examined together.

The areas viewed especially carefully in clinical practice are as follows.

• Abnormal uterine bleeding: postmenopausal bleeding or irregular heavy bleeding must be evaluated.
• Decreased bone density: estrogen deficiency accelerates bone loss and raises the risk of osteoporosis.
• Genitourinary syndrome of menopause: vaginal dryness, recurrent bladder irritation, painful intercourse.
• Metabolic change: the part that can lead to changes in weight, lipids, and blood pressure.

Of these, the first signal to address is bleeding. Vaginal bleeding after menopause is confirmed is regarded not as a resumption of normal menstruation but as a symptom needing examination. The UK NICE menopause guideline (NG23) also recommends getting care promptly for unscheduled postmenopausal bleeding to differentiate causes such as endometrial cancer. This topic is addressed in detail in postmenopausal bleeding is not menstruation.

Bone health must also be cared for in earnest during the menopausal period. When estrogen decreases, the speed of bone resorption outpaces the speed of bone formation and bone density drops; a considerable part of postmenopausal women's osteoporosis is related to this estrogen deficiency (various endocrine and orthopedic reviews, 2017-2023). Diagnosis and prevention methods are organized in menopause and osteoporosis diagnosis and prevention.

To say the conclusion first, when the menstrual pattern changes or climacteric symptoms appear is the right time for screening. The changes around menopause are a natural process, but a signal needing examination may be hidden within that change.

In the following cases, we recommend getting care without putting it off.

• When the menstrual cycle becomes irregular or the flow noticeably changes
• When there is vaginal bleeding again after menopause has been confirmed
• When climacteric symptoms such as facial flushing, sleep disturbance, and mood change affect daily life
• When there is vaginal dryness, painful intercourse, or recurrent bladder discomfort

The background on climacteric symptoms in general can be read further in menopausal body changes and symptoms, causes and mechanisms, and on bone health around age 50 in the story of bone health for women in their 50s. Since the type, intensity, and duration of symptoms vary greatly between individuals, it is safer to set a management direction fitted to your state through care, rather than judging alone.

Menopause is not an end but the starting point of examination for the health of the following decades. If you are uncomfortable with symptoms or curious about the timing of examination, please feel free to request a consultation.

If you are curious about menopausal symptoms and the timing of screening, get a chat consultation

Written by: Lee Dong-hee Director · OB-GYN specialist · View medical staff profile

First published November 24, 2023 · Last reviewed May 30, 2026

References: North American Menopause Society Position Statements (2015, 2022), Avis et al. SWAN Duration of Menopausal Vasomotor Symptoms (2015), NICE Menopause Guideline NG23 (2024), ISSWSH and NAMS Genitourinary Syndrome of Menopause (2014), Korea Disease Control and Prevention Agency National Health Information Portal Menopause (2023)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through an examination.